Financials data is unavailable for this security.
View more
Year on year Twist Bioscience Corp grew revenues 20.41% from 203.57m to 245.11m while net income improved from a loss of 217.86m to a smaller loss of 204.62m.
| Gross margin | 40.53% |
|---|---|
| Net profit margin | -74.63% |
| Operating margin | -79.57% |
| Return on assets | -30.42% |
|---|---|
| Return on equity | -38.36% |
| Return on investment | -33.85% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Twist Bioscience Corp fell by 90.98m. However, Cash Flow from Investing totalled 50.61m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 142.47m for operations while cash generated from financing totalled 911.00k.
| Cash flow per share | -3.24 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 8.39 |
|---|---|
| Tangible book value per share | 6.67 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.91 |
|---|---|
| Quick ratio | 4.52 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
